Search Results 261-270 of 16117 for SC

  1. Publications - Claire Tiger, M.D., Ph.D. - Mayo Clinic

    Updates on Therapeutic Strategies in the Treatment of Relapsed/Refractory Multiple Myeloma Cancers. 2024; 16(17):2931. McKenna M, Ryu Tiger YK, Rutherford SC, ...

  2. A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma (SubQSA) - Mayo Clinic

    The primary purpose of this study is to assess the efficacy (overall response rate) of subcutaneous (SC) via on body delivery system (SC-OBDS) isatuximab ...

  3. A Study To Evaluate Efficacy Of Remibrutinib Compared To Dupilumab At Early Timepoints In Adults With Chronic Spontaneous Urticaria Inadequately Controlled By Second Generation H1-antihistamines - Mayo Clinic

    ... (s.c.) followed by 300 mg every 2 weeks s.c.) at early timepoints (4 weeks and earlier), when administered as an add-on treatment to second generation H1 ...

  4. Dislocated shoulder - Diagnosis and treatment - Mayo Clinic

    Sherman SC. Shoulder dislocation and reduction. http://www.uptodate.com/contents/search. Accessed June 9, 2022. Dislocated shoulder. American Academy of ...

  5. Knee Arthritis Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine the safety of sc-rAAV2.5IL-1Ra, a gene therapy carried by a virus and delivered by injection into the knee joint of ...

  6. Publications - Brad S. Karon, M.D., Ph.D. - Mayo Clinic

    Epub 1900 Jan 01. Karon BS, Meeusen JW, Bryant SC. Impact of Glucose Meter Error on Glycemic Variability and Time in Target Range During Glycemic Control After ...

  7. Glucagon (injection route) - Side effects & dosage - Mayo Clinic

    Glucagon injection is an emergency medicine used to treat severe hypoglycemia (low blood sugar) in diabetes patients treated with insulin who have passed out or ...

  8. A Study to Evaluate the Safety and Effectiveness of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    At least one 4-week induction regimen of adalimumab (one 160 mg subcutaneous [SC] dose at Baseline, followed by one 80 mg SC dose at Week 2 [or one 80 mg SC ...

  9. Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) (ESSENCE) - Mayo Clinic

    The primary objective for PART 1 of this study is to demonstrate that treatment with semaglutide s.c. 2.4 mg improves liver histology compared to placebo in ...

  10. Publications - Gary L. Keeney, M.D. - Mayo Clinic

    AlHilli MM, Bakkum-Gamez JN, Mariani A, Weaver AL, McGree ME, Keeney GL, Jatoi A, Dowdy SC, Podratz KC. Risk-adjusted outcomes in elderly endometrial cancer ...